Cargando…
Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer’s Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells
Stem-cell-based therapy is very promising for Alzheimer’s disease (AD), yet has not become a reality. A critical challenge is the transplantation microenvironment, which impacts the therapeutic effect of stem cells. In AD brains, amyloid-beta (Aβ) peptides and inflammatory cytokines continuously poi...
Autores principales: | Cheng, Qing, Ma, Xiaoli, Liu, Jingjing, Feng, Xuemei, Liu, Yan, Wang, Yanxia, Ni, Wenwen, Song, Mingke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178525/ https://www.ncbi.nlm.nih.gov/pubmed/37175445 http://dx.doi.org/10.3390/ijms24097739 |
Ejemplares similares
-
Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease
por: Wang, Shan-Shan, et al.
Publicado: (2021) -
The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer’s Disease
por: Song, Mingke
Publicado: (2022) -
One-step asparaginyl endopeptidase (OaAEP1)-based protein immobilization for single-molecule force spectroscopy
por: Ding, Xuan, et al.
Publicado: (2022) -
Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model
por: Wang, Ju, et al.
Publicado: (2021) -
Asparaginyl endopeptidases: enzymology, applications and limitations
por: Tang, T. M. Simon, et al.
Publicado: (2021)